Meet the Systane® Family
Designed for different Dry Eye Needs
Explore the Systane® range with specially designed formulations that address different types of patient's dry eye needs. Find the Systane® eye drop that is appropriate for your patient, depending on their symptoms and underlying causes. Also, learn more about Systane® proprietary HP-Guar® Intelligent Delivery System2 and its benefits that make Systane® the #1 Dry Eye brand in Australia & New Zealand.
HP-Guar -Technology
Hydroxypropyl-guar, or HP-Guar, acts as a gelling agent, creating an elastic matrix on the corneal surface upon instillation,2 producing a protective environment and forming a bio-adhesive gel that binds specifically to the hydrophobic regions of the cornea, where integrity is compromised.3
Benefits of HP-Guar include:
- Increased retention4
- Prolonged protection4
- Greater hydration and lubrication compared to HA alone4
For All Types of Dry Eye†
Some patients suffer from a combination of both the Evaporative Dry Eye, with tears evaporating too quickly, and the Aqueous Deficient Dry Eye, where the lacrimal gland doesn’t product enough tear fluid.5 The All-In-One Dry Eye relief is now Preservative-Free.
For Aqueous Deficient Dry Eye
Aqueous Deficient Dry Eye indicates Dry Eye as a result of a lacrimal gland tear secretion defect. Essentially, the lacrimal gland doesn’t produce enough tear fluid5.
Also, learn more about our PRESERVATIVE-FREE products.
For Evaporative Dry Eye
As the name suggests, tears evaporate too quickly but lacrimation (watering) is normal.5 One of the leading causes is Meibomian Gland Dysfunction (MGD).5
Other Dry Eye Products
Discover more products to help your patients manage their Dry Eye symptoms.
†Dry eye and associated symptoms due to aqueous deficient, evaporative and mixed dry eye, DEWS II 2017
References:
1. Based on internal calculations using third-party data; Alcon data on file, 2019.
2. Clark L. Springs, Novel Hydroxypropyl-Guar Gellable Lubricant Eye Drops for Treatment of Dry Eye, Adv Ther (2010).
3. Mrukwa-Kominek E, Baranska K, Jadczyk K. First clinical reports on the application of the moderndualpolymer formula in aqueous deficiency dry eye syndrome: Polish observations. Presented at the 20th ESCRS Winter Meeting; February 26-28, 2016, Athens, Greece.
4. Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.
5. Bron et al. TFOS DEWS II Pathophysiology Report The Ocular Surface 2017; 15(3): 438-510.
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE.
All content on this website is for informational purposes only, always talk to your health professional regarding your eye health or medical conditions.
